Title:
３－［５－（２－フルオロフェニル）－［１，２，４］オキサジアゾール－３－イル］－安息香酸の結晶形
Document Type and Number:
Japanese Patent JP7245868
Kind Code:
B2
Abstract:
The present invention relates to preparation processes for crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, pharmaceutical compositions and dosage forms comprising the crystalline forms, methods of making the crystalline forms and methods for their use for the treatment, prevention or management of diseases ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay.
Inventors:
Nail G. Almstead
Peter Seongwoo Hwang
Young-gu Choon Mo-on
Peter Seongwoo Hwang
Young-gu Choon Mo-on
Application Number:
JP2021090763A
Publication Date:
March 24, 2023
Filing Date:
May 31, 2021
Export Citation:
Assignee:
PTC Therapeutics, Incorporated
International Classes:
C07D271/06
Domestic Patent References:
| JP2010504340A | ||||
| JP2015110607A | ||||
| JP2017160253A | ||||
| JP2019104752A |
Foreign References:
| WO2004091502A2 | ||||
| WO2006044456A1 |
Attorney, Agent or Firm:
Toru Ishikawa
Previous Patent: Polyphenol condensate and its epoxy resin
Next Patent: INSULATION DETERIORATION DETECTION DEVICE FOR ELECTRIC EQUIPMENT
Next Patent: INSULATION DETERIORATION DETECTION DEVICE FOR ELECTRIC EQUIPMENT